vs
达尔科技（DIOD）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
达尔科技的季度营收约是REPLIGEN CORP的2.0倍（$391.6M vs $197.9M），REPLIGEN CORP净利率更高（6.7% vs 2.6%，领先4.1%），达尔科技同比增速更快（15.4% vs 13.6%），REPLIGEN CORP自由现金流更多（$17.6M vs $12.4M），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs 13.9%）
达尔科技是一家全球性半导体制造商，主营分立器件、模拟及混合信号半导体产品的设计、生产与销售，产品广泛应用于汽车、工业、消费电子、计算及通信基础设施等核心领域，服务全球各地客户。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
DIOD vs RGEN — 直观对比
营收规模更大
DIOD
是对方的2.0倍
$197.9M
营收增速更快
DIOD
高出1.8%
13.6%
净利率更高
RGEN
高出4.1%
2.6%
自由现金流更多
RGEN
多$5.1M
$12.4M
两年增速更快
RGEN
近两年复合增速
13.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $391.6M | $197.9M |
| 净利润 | $10.2M | $13.3M |
| 毛利率 | 31.1% | 52.5% |
| 营业利润率 | 3.4% | 9.0% |
| 净利率 | 2.6% | 6.7% |
| 营收同比 | 15.4% | 13.6% |
| 净利润同比 | 23.8% | 143.9% |
| 每股收益（稀释后） | $0.23 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DIODRGEN
| Q4 25 | $391.6M | $197.9M | ||
| Q3 25 | $392.2M | $188.8M | ||
| Q2 25 | $366.2M | $182.4M | ||
| Q1 25 | $332.1M | $169.2M | ||
| Q4 24 | $339.3M | $174.1M | ||
| Q3 24 | $350.1M | $154.9M | ||
| Q2 24 | $319.8M | $154.1M | ||
| Q1 24 | $302.0M | $151.3M |
净利润DIODRGEN
| Q4 25 | $10.2M | $13.3M | ||
| Q3 25 | $14.3M | $14.9M | ||
| Q2 25 | $46.1M | $14.9M | ||
| Q1 25 | $-4.4M | $5.8M | ||
| Q4 24 | $8.2M | $-30.3M | ||
| Q3 24 | $13.7M | $-654.0K | ||
| Q2 24 | $8.0M | $3.3M | ||
| Q1 24 | $14.0M | $2.1M |
毛利率DIODRGEN
| Q4 25 | 31.1% | 52.5% | ||
| Q3 25 | 30.7% | 53.2% | ||
| Q2 25 | 31.5% | 50.0% | ||
| Q1 25 | 31.5% | 53.6% | ||
| Q4 24 | 32.7% | 26.1% | ||
| Q3 24 | 33.7% | 50.0% | ||
| Q2 24 | 33.6% | 49.8% | ||
| Q1 24 | 33.0% | 49.5% |
营业利润率DIODRGEN
| Q4 25 | 3.4% | 9.0% | ||
| Q3 25 | 3.0% | 8.9% | ||
| Q2 25 | 2.6% | 7.6% | ||
| Q1 25 | 0.4% | 3.9% | ||
| Q4 24 | 3.5% | -17.7% | ||
| Q3 24 | 6.2% | -5.1% | ||
| Q2 24 | 1.2% | 1.0% | ||
| Q1 24 | 4.3% | 1.3% |
净利率DIODRGEN
| Q4 25 | 2.6% | 6.7% | ||
| Q3 25 | 3.6% | 7.9% | ||
| Q2 25 | 12.6% | 8.2% | ||
| Q1 25 | -1.3% | 3.4% | ||
| Q4 24 | 2.4% | -17.4% | ||
| Q3 24 | 3.9% | -0.4% | ||
| Q2 24 | 2.5% | 2.2% | ||
| Q1 24 | 4.6% | 1.4% |
每股收益（稀释后）DIODRGEN
| Q4 25 | $0.23 | $0.24 | ||
| Q3 25 | $0.31 | $0.26 | ||
| Q2 25 | $0.99 | $0.26 | ||
| Q1 25 | $-0.10 | $0.10 | ||
| Q4 24 | $0.18 | $-0.55 | ||
| Q3 24 | $0.30 | $-0.01 | ||
| Q2 24 | $0.17 | $0.06 | ||
| Q1 24 | $0.30 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $377.0M | $767.6M |
| 总债务越低越好 | $25.7M | $542.2M |
| 股东权益账面价值 | $1.9B | $2.1B |
| 总资产 | $2.4B | $2.9B |
| 负债/权益比越低杠杆越低 | 0.01× | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资DIODRGEN
| Q4 25 | $377.0M | $767.6M | ||
| Q3 25 | $386.4M | $748.7M | ||
| Q2 25 | $327.3M | $708.9M | ||
| Q1 25 | $343.9M | $697.2M | ||
| Q4 24 | $316.1M | $757.4M | ||
| Q3 24 | $319.3M | $784.0M | ||
| Q2 24 | $273.9M | $809.1M | ||
| Q1 24 | $276.0M | $780.6M |
总债务DIODRGEN
| Q4 25 | $25.7M | $542.2M | ||
| Q3 25 | $24.9M | $537.9M | ||
| Q2 25 | $26.4M | — | ||
| Q1 25 | $20.5M | — | ||
| Q4 24 | $20.7M | $525.6M | ||
| Q3 24 | $22.2M | — | ||
| Q2 24 | $20.3M | — | ||
| Q1 24 | $20.9M | — |
股东权益DIODRGEN
| Q4 25 | $1.9B | $2.1B | ||
| Q3 25 | $1.9B | $2.1B | ||
| Q2 25 | $1.9B | $2.1B | ||
| Q1 25 | $1.8B | $2.0B | ||
| Q4 24 | $1.8B | $2.0B | ||
| Q3 24 | $1.8B | $2.0B | ||
| Q2 24 | $1.8B | $2.0B | ||
| Q1 24 | $1.7B | $2.0B |
总资产DIODRGEN
| Q4 25 | $2.4B | $2.9B | ||
| Q3 25 | $2.5B | $2.9B | ||
| Q2 25 | $2.5B | $2.9B | ||
| Q1 25 | $2.4B | $2.9B | ||
| Q4 24 | $2.4B | $2.8B | ||
| Q3 24 | $2.4B | $2.8B | ||
| Q2 24 | $2.4B | $2.9B | ||
| Q1 24 | $2.4B | $2.8B |
负债/权益比DIODRGEN
| Q4 25 | 0.01× | 0.26× | ||
| Q3 25 | 0.01× | 0.26× | ||
| Q2 25 | 0.01× | — | ||
| Q1 25 | 0.01× | — | ||
| Q4 24 | 0.01× | 0.27× | ||
| Q3 24 | 0.01× | — | ||
| Q2 24 | 0.01× | — | ||
| Q1 24 | 0.01× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $38.1M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $12.4M | $17.6M |
| 自由现金流率自由现金流/营收 | 3.2% | 8.9% |
| 资本支出强度资本支出/营收 | 6.6% | 4.1% |
| 现金转化率经营现金流/净利润 | 3.74× | 1.93× |
| 过去12个月自由现金流最近4个季度 | $137.2M | $93.9M |
8季度趋势，按日历期对齐
经营现金流DIODRGEN
| Q4 25 | $38.1M | $25.7M | ||
| Q3 25 | $79.1M | $48.1M | ||
| Q2 25 | $41.5M | $28.6M | ||
| Q1 25 | $56.7M | $15.0M | ||
| Q4 24 | $81.8M | $39.2M | ||
| Q3 24 | $54.4M | $49.3M | ||
| Q2 24 | $14.4M | $42.2M | ||
| Q1 24 | $-31.1M | $44.7M |
自由现金流DIODRGEN
| Q4 25 | $12.4M | $17.6M | ||
| Q3 25 | $62.8M | $43.4M | ||
| Q2 25 | $21.1M | $21.5M | ||
| Q1 25 | $40.8M | $11.4M | ||
| Q4 24 | $62.1M | $33.6M | ||
| Q3 24 | $39.4M | $42.3M | ||
| Q2 24 | $-3.5M | $37.4M | ||
| Q1 24 | $-51.5M | $36.4M |
自由现金流率DIODRGEN
| Q4 25 | 3.2% | 8.9% | ||
| Q3 25 | 16.0% | 23.0% | ||
| Q2 25 | 5.8% | 11.8% | ||
| Q1 25 | 12.3% | 6.8% | ||
| Q4 24 | 18.3% | 19.3% | ||
| Q3 24 | 11.2% | 27.3% | ||
| Q2 24 | -1.1% | 24.3% | ||
| Q1 24 | -17.1% | 24.0% |
资本支出强度DIODRGEN
| Q4 25 | 6.6% | 4.1% | ||
| Q3 25 | 4.2% | 2.5% | ||
| Q2 25 | 5.6% | 3.9% | ||
| Q1 25 | 4.8% | 2.1% | ||
| Q4 24 | 5.8% | 3.2% | ||
| Q3 24 | 4.3% | 4.5% | ||
| Q2 24 | 5.6% | 3.1% | ||
| Q1 24 | 6.7% | 5.5% |
现金转化率DIODRGEN
| Q4 25 | 3.74× | 1.93× | ||
| Q3 25 | 5.54× | 3.23× | ||
| Q2 25 | 0.90× | 1.92× | ||
| Q1 25 | — | 2.57× | ||
| Q4 24 | 9.93× | — | ||
| Q3 24 | 3.95× | — | ||
| Q2 24 | 1.80× | 12.70× | ||
| Q1 24 | -2.22× | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DIOD
| Distributor | $253.1M | 65% |
| Direct Sales | $138.5M | 35% |
RGEN
暂无分部数据
